Concluding, our study provides evidence that disruptive mutations of ZNF217 frequently found in aggressive lymphomas interfere with histone modifications at genes that control major hallmarks of lymphomagenesis such as cytokine signaling, B cell differentiation and interactions within the immune cell compartment. Here, ZNF217 is linked to lymphoma.